Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0787B in nosocomial pneumonia
NCT00445094Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2006
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of imipenem, cilastatin in hospital-acquired pneumonia (HAP), sponsored by Merck & Co.. Started Nov 2006; status: completed.
02
Drugs
imipenemcilastatin
03
Conditions
hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on NCT00445094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445094.